| Literature DB >> 29034993 |
Cheng Xu1, Xu Liu1, Yu-Pei Chen1, Yan-Ping Mao1, Rui Guo1, Guan-Qun Zhou1, Ling-Long Tang1, Ai-Hua Lin2, Ying Sun1, Jun Ma1.
Abstract
The impact of marital status at diagnosis on survival outcomes and its change over time in patients with nasopharyngeal carcinoma (NPC) are unclear. The Surveillance, Epidemiology, and End Results (SEER) database was used to identify patients diagnosed with NPC in the United States from 1973 to 2012. A primary comparison (married vs. unmarried) was implemented with 1:1 propensity score matching. Secondary comparisons were performed individually between three unmarried subgroups (single, separated/divorced, widowed) and married group. The effect of marital status on cause-specific survival (CSS) and overall survival (OS) were evaluated using univariate/multivariate analysis. Moreover, we investigated the change over time (1973-2012) in the effect of marital status on NPC survival. Married patients had better 5-year CSS/OS than unmarried patients (61.1% vs. 52.6%, P < 0.001; 55.6% vs. 45.3%, P < 0.001, respectively). In multivariate analysis, unmarried patients had significantly poorer CSS/OS than married patients (adjusted hazard ratio [aHR] = 1.35, P < 0.001; aHR = 1.40, P < 0.001, respectively). The survival benefit of being married was only detected in non-Hispanic white and Chinese American patients. Single, separated/divorced, and widowed patients had significantly poorer CSS/OS than married patients (aHR = 1.37 and 1.37; 1.46 and 1.42; 1.43 and 1.48, respectively; all P < 0.001). The change over time in the effect of marital status on survival was more stable in male than female. The strength of the negative effect of separated/divorced and widowed status showed a downward and upward trend, respectively. Gender difference in the adverse effect of single status on NPC survival became smaller over time. Only non-Hispanic white and Chinese American patients with NPC obtain survival benefits from married status. Single and widowed patients are regarded as high-risk population.Entities:
Keywords: zzm321990SEERzzm321990; Marital status; nasopharyngeal carcinoma; propensity score-matched analysis; survival
Mesh:
Year: 2017 PMID: 29034993 PMCID: PMC5727244 DOI: 10.1002/cam4.1232
Source DB: PubMed Journal: Cancer Med ISSN: 2045-7634 Impact factor: 4.452
Figure 1Flowchart describing the inclusion and exclusion of patients.
Baseline characteristics of the married and unmarried patients with NPC in the original/matched data sets
| Characteristics | Original data set | Matched data set | ||||
|---|---|---|---|---|---|---|
| Married ( | Unmarried ( |
| Married ( | Unmarried ( |
| |
| Follow‐up time | – | – | ||||
| Median, months | 146 | 136 | 132 | 136 | ||
| IQR, months | 76–259 | 66–239 | 67–241 | 66–240 | ||
| No. of death at 5‐year | – | – | ||||
| Cause‐specific | 1984 (34.3) | 1239 (42.5) | 1022 (35.2) | 1234 (42.4) | ||
| Overall | 2397 (41.4) | 1508 (51.7) | 1205 (41.5) | 1500 (51.6) | ||
| Age at diagnosis | 0.007 | 0.138 | ||||
| ≤50 years | 2260 (39.1) | 1226 (42.0) | 1280 (44.0) | 1224 (42.1) | ||
| Mean ± SD, years | 41.65 ± 6.45 | 36.85 ± 9.84 | 41.42 ± 6.68 | 36.85 ± 9.84 | ||
| >50 years | 3526 (60.9) | 1690 (58.0) | 1627 (56.0) | 1683 (57.9) | ||
| Mean ± SD, years | 62.92 ± 8.64 | 65.13 ± 10.07 | 63.49 ± 8.75 | 65.11 ± 10.06 | ||
| Gender | <0.001 | 0.358 | ||||
| Male | 4302 (74.4) | 1791 (61.4) | 1825 (62.8) | 1791 (61.6) | ||
| Female | 1484 (25.6) | 1125 (38.6) | 1082 (37.2) | 1116 (38.4) | ||
| Race/ethnicity | <0.001 | <0.001 | ||||
| Non‐Hispanic white | 2303 (39.8) | 1330 (45.6) | 1433 (49.3) | 1323 (45.5) | ||
| Non‐Hispanic black | 302 (5.2) | 388 (13.3) | 174 (6.0) | 386 (13.3) | ||
| Hispanic | 341 (5.9) | 254 (8.7) | 177 (6.1) | 254 (8.7) | ||
| Chinese | 1413 (24.4) | 388 (13.3) | 579 (19.9) | 388 (13.3) | ||
| Other | 1427 (24.7) | 556 (19.1) | 544 (18.7) | 556 (19.1) | ||
| Registry region | <0.001 | 0.845 | ||||
| West | 4123 (71.3) | 1913 (65.6) | 1924 (66.2) | 1907 (65.6) | ||
| Northeast | 655 (11.3) | 379 (13.0) | 378 (13.0) | 376 (12.9) | ||
| North central | 679 (11.7) | 395 (13.5) | 394 (13.6) | 395 (13.6) | ||
| South | 329 (5.7) | 229 (7.9) | 211 (7.3) | 229 (7.9) | ||
| SEER historic stage | <0.001 | 0.464 | ||||
| Localized | 700 (12.1) | 282 (9.7) | 293 (10.1) | 282 (9.7) | ||
| Regional | 3300 (57.0) | 1531 (52.5) | 1566 (53.9) | 1531 (52.7) | ||
| Distant | 1450 (25.1) | 884 (30.3) | 826 (28.4) | 881 (30.3) | ||
| Unstaged | 336 (5.8) | 219 (7.5) | 222 (7.6) | 213 (7.3) | ||
| Histological type | <0.001 | 0.054 | ||||
| Keratinizing | 2182 (37.7) | 1203 (41.3) | 1160 (39.9) | 1198 (41.2) | ||
| Differentiated non‐keratinizing | 889 (15.4) | 395 (13.5) | 454 (15.6) | 395 (13.6) | ||
| Undifferentiated non‐keratinizing | 1236 (21.4) | 542 (18.6) | 575 (19.8) | 542 (18.6) | ||
| Other | 1479 (25.6) | 776 (26.6) | 718 (24.7) | 772 (26.6) | ||
| Year of diagnosis | <0.001 | 0.070 | ||||
| 1973–1982 | 752 (13.0) | 301 (10.3) | 347 (11.9) | 300 (10.3) | ||
| 1983–1992 | 891 (15.4) | 427 (14.6) | 390 (13.4) | 427 (14.7) | ||
| 1993–2002 | 1798 (31.1) | 894 (30.7) | 841 (28.9) | 890 (30.6) | ||
| 2003–2012 | 2345 (40.5) | 1294 (44.4) | 1329 (45.7) | 1290 (44.4) | ||
| Treatment | <0.001 | 0.162 | ||||
| Surgery and/or RT | 5231 (90.4) | 2481 (85.1) | 2518 (86.6) | 2481 (85.3) | ||
| No definitive treatment | 555 (9.6) | 435 (14.9) | 389 (13.4) | 426 (14.7) | ||
NPC, nasopharyngeal carcinoma; IQR, interquartile range; SEER, Surveillance, Epidemiology, and End Results Program; no., number; SD, standard deviation; RT, radiotherapy.
“Age at diagnosis” was analyzed as categorical measurement (age ≤50; age >50).
“Other” includes American Indian/Alaska Native, Asian/Pacific Islander, and unknown.
“West” includes Seattle‐Puget Sound, Greater California, San Francisco‐Oakland, San Jose‐Monterey, Los Angeles, Utah, New Mexico, Alaska, and Hawaii. “Northeast” includes Connecticut and New Jersey. “North central” includes Iowa and Detroit. “South” includes Kentucky, Atlanta, Rural Georgia, Greater Georgia, and Louisiana.
Percentages may not add up to 100 because of rounding.
Figure 2Kaplan–Meier survival curves in patients with NPC of different race/ethnicity. Survival curves for CSS (A–E) and OS (F–J) were stratified by marital status. (A, F) All races/ethnicities; (B, G) Non‐Hispanic white; (C, H) Non‐Hispanic black; (D, I) Hispanic; (E, J) Chinese. CSS, cause‐specific survival; OS, overall survival; HR, hazard ratio; CI, confidence interval; No., number; NPC, nasopharyngeal carcinoma.
Univariate and multivariate analysis of the effect of marital status on survival outcomes in NPC
| Variables | CSS | OS | ||||||
|---|---|---|---|---|---|---|---|---|
| Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||
| HR (95% CI) |
| aHR (95% CI)a |
| HR (95% CI) |
| aHR (95% CI) |
| |
| Age at diagnosis | ||||||||
| ≤50 years | Reference | Reference | Reference | Reference | ||||
| >50 years | 1.84 (1.68–2.01) | <0.001 | 1.63 (1.49–1.78) | <0.001 | 2.05 (1.89–2.22) | <0.001 | 1.84 (1.69–2.00) | <0.001 |
| Gender | ||||||||
| Male | Reference | Reference | Reference | Reference | ||||
| Female | 0.85 (0.78–0.92) | <0.001 | 0.88 (0.81–0.96) | 0.005 | 0.88 (0.81–0.95) | 0.001 | 0.90 (0.83–0.97) | 0.006 |
| Race/ethnicity | ||||||||
| Non‐Hispanic white | Reference | Reference | Reference | Reference | ||||
| Non‐Hispanic black | 0.94 (0.82–1.08) | 0.403 | 0.92 (0.80–1.05) | 0.216 | 0.96 (0.85–1.08) | 0.500 | 0.93 (0.82–1.06) | 0.282 |
| Hispanic | 0.74 (0.63–0.88) | 0.001 | 0.85 (0.72–1.01) | 0.072 | 0.76 (0.65–0.89) | <0.001 | 0.91 (0.78–1.07) | 0.247 |
| Chinese | 0.50 (0.44–0.57) | <0.001 | 0.66 (0.58–0.76) | <0.001 | 0.49 (0.44–0.55) | <0.001 | 0.69 (0.60–0.78) | <0.001 |
| Other | 0.60 (0.54–0.68) | <0.001 | 0.72 (0.63–0.81) | <0.001 | 0.59 (0.53–0.66) | <0.001 | 0.74 (0.66–0.84) | <0.001 |
| Registry region | ||||||||
| West | Reference | Reference | Reference | Reference | ||||
| Northeast | 1.21 (1.07–1.36) | 0.003 | 1.01 (0.89–1.15) | 0.843 | 1.21 (1.08–1.36) | 0.001 | 1.01 (0.90–1.14) | 0.836 |
| North central | 1.38 (1.23–1.56) | <0.001 | 1.04 (0.91–1.18) | 0.578 | 1.47 (1.32–1.63) | <0.001 | 1.10 (0.98–1.23) | 0.117 |
| South | 1.35 (1.16–1.56) | <0.001 | 1.21 (1.04–1.42) | 0.017 | 1.34 (1.17–1.54) | <0.001 | 1.21 (1.04–1.39) | 0.011 |
| SEER historic stage | ||||||||
| Localized | Reference | Reference | Reference | Reference | ||||
| Regional | 1.54 (1.30–1.84) | <0.001 | 1.78 (1.50–2.13) | <0.001 | 1.37 (1.18–1.60) | <0.001 | 1.62 (1.39–1.88) | <0.001 |
| Distant | 2.64 (2.21–3.15) | <0.001 | 3.26 (2.72–3.91) | <0.001 | 2.28 (1.95–2.66) | <0.001 | 2.86 (2.44–3.35) | <0.001 |
| Unstaged | 2.18 (1.76–2.70) | <0.001 | 1.63 (1.31–2.02) | <0.001 | 1.92 (1.59–2.32) | <0.001 | 1.46 (1.21–1.77) | <0.001 |
| Histological type | ||||||||
| Keratinizing | Reference | Reference | Reference | Reference | ||||
| Differentiated non‐keratinizing | 0.52 (0.46–0.60) | <0.001 | 0.66 (0.58–0.76) | <0.001 | 0.53 (0.47–0.60) | <0.001 | 0.68 (0.60–0.77) | <0.001 |
| Undifferentiated non‐keratinizing | 0.43 (0.38–0.48) | <0.001 | 0.54 (0.47–0.62) | <0.001 | 0.43 (0.39–0.49) | <0.001 | 0.57 (0.50–0.64) | <0.001 |
| Other | 0.67 (0.60–0.74) | <0.001 | 0.76 (0.68–0.84) | <0.001 | 0.68 (0.62–0.75) | <0.001 | 0.79 (0.71–0.86) | <0.001 |
| Year of diagnosis | ||||||||
| 1973–1982 | Reference | Reference | Reference | Reference | ||||
| 1983–1992 | 0.86 (0.74–0.99) | 0.037 | 0.91 (0.89–1.05) | 0.213 | 0.85 (0.74–0.97) | 0.014 | 0.90 (0.79–1.03) | 0.129 |
| 1993–2002 | 0.63 (0.55–0.72) | <0.001 | 0.75 (0.65–0.85) | <0.001 | 0.62 (0.55–0.70) | <0.001 | 0.74 (0.66–0.84) | <0.001 |
| 2003–2012 | 0.58 (0.51–0.66) | <0.001 | 0.52 (0.46–0.59) | <0.001 | 0.58 (0.51–0.65) | <0.001 | 0.53 (0.47–0.59) | <0.001 |
| Treatment | ||||||||
| Surgery and/or RT | Reference | Reference | Reference | Reference | ||||
| No definitive treatment | 2.79 (2.53–3.09) | <0.001 | 2.81 (2.53–3.12) | <0.001 | 2.67 (2.43–2.92) | <0.001 | 2.71 (2.46–2.98) | <0.001 |
| Marital status | ||||||||
| Married | Reference | Reference | Reference | Reference | ||||
| Unmarried | 1.35 (1.24–1.46) | <0.001 | 1.35 (1.24–1.47) | <0.001 | 1.39 (1.29–1.50) | <0.001 | 1.40 (1.29–1.51) | <0.001 |
NPC, nasopharyngeal carcinoma; CSS, cause‐specific survival; OS, overall survival; aHR, adjusted hazard ratio; CI, confidence interval; RT, radiotherapy; SEER, Surveillance, Epidemiology, and End Results Program.
aHR was adjusted for demographics (age at diagnosis, gender, race/ethnicity), registry region, SEER historic stage, histological type, year of diagnosis, and treatment.
Subgroup analysis of the effect of marital status on survival outcomes in NPC
| Subgroups | CCS | OS | ||
|---|---|---|---|---|
| aHR (95% CI) |
| aHR (95% CI) |
| |
| Race/ethnicity | ||||
| Non‐Hispanic white | 1.49 (1.33–1.67) | <0.001 | 1.48 (1.33–1.64) | <0.001 |
| Non‐Hispanic black | 1.11 (0.84–1.47) | 0.449 | 1.22 (0.95–1.57) | 0.126 |
| Hispanic | 0.97 (0.69–1.36) | 0.875 | 1.11 (0.82–1.50) | 0.501 |
| Chinese | 1.29 (1.01–1.64) | 0.041 | 1.38 (1.10–1.72) | 0.005 |
| Other | 1.21 (0.98–1.50) | 0.079 | 1.23 (1.01–1.50) | 0.041 |
| Age at diagnosis | ||||
| ≤50 years | 1.24 (1.07–1.44) | 0.004 | 1.26 (1.10–1.45) | 0.001 |
| >50 years | 1.38 (1.25–1.53) | <0.001 | 1.43 (1.30–1.57) | <0.001 |
| Gender | ||||
| Male | 1.35 (1.22–1.50) | <0.001 | 1.43 (1.29–1.57) | <0.001 |
| Female | 1.31 (1.13–1.51) | <0.001 | 1.30 (1.14–1.49) | <0.001 |
| SEER historic stage | ||||
| Localized | 1.67 (1.20–2.34) | 0.003 | 1.66 (1.24–2.22) | 0.001 |
| Regional | 1.37 (1.21–1.54) | <0.001 | 1.41 (1.26–1.57) | <0.001 |
| Distant | 1.34 (1.16–1.55) | <0.001 | 1.42 (1.25–1.63) | <0.001 |
| Unstaged | 1.10 (0.83–1.47) | 0.496 | 1.01 (0.78–1.32) | 0.935 |
| Histological type | ||||
| Keratinizing | 1.43 (1.27–1.61) | <0.001 | 1.45 (1.30–1.62) | <0.001 |
| Differentiated non‐keratinizing | 1.50 (1.17–1.92) | 0.001 | 1.56 (1.25–1.96) | <0.001 |
| Undifferentiated non‐keratinizing | 1.40 (1.11–1.76) | 0.004 | 1.44 (1.17–1.77) | 0.001 |
| Other | 1.11 (0.93–1.31) | 0.253 | 1.16 (0.99–1.35) | 0.066 |
| Treatment | ||||
| Surgery and/or radiotherapy | 1.29 (1.18–1.42) | <0.001 | 1.36 (1.25–1.48) | <0.001 |
| No definitive treatment | 1.54 (1.28–1.84) | <0.001 | 1.46 (1.23–1.73) | <0.001 |
| Year of diagnosis | ||||
| 1973–1982 | 1.25 (0.99–1.56) | 0.056 | 1.16 (0.95–1.41) | 0.146 |
| 1983–1992 | 1.53 (1.25–1.87) | <0.001 | 1.62 (1.34–1.95) | <0.001 |
| 1993–2002 | 1.22 (1.05–1.43) | 0.012 | 1.26 (1.09–1.45) | 0.002 |
| 2003–2012 | 1.40 (1.22–1.60) | <0.001 | 1.43 (1.26–1.63) | <0.001 |
NPC, nasopharyngeal carcinoma; CSS, cause‐specific survival; OS, overall survival; aHR, adjusted hazard ratio; CI, confidence interval; SEER, Surveillance, Epidemiology, and End Results Program.
“Married” was used as reference compared to “unmarried”.
aHR was adjusted for demographics (age at diagnosis, gender, race/ethnicity), registry region, SEER historic stage, histological type, year of diagnosis, and treatment, except for the variable that is being analyze.
Figure 3The effect of marital status on CSS and OS in the secondary comparison. Squares represent the aHRs with the 95% CIs indicated by horizontal bars. CSS, cause‐specific survival; OS, overall survival; aHR, adjusted hazard ratio; CI, confidence interval; no., number; Ref., reference.
Figure 4Change over time in the effect of marital status on survival outcomes. The left and right panel represent the change in the effect of marital status on CSS (A, C, E, G) and OS (B, D, F, H), respectively. Squares and circles represent the HRs of the association between marital status (unmarried vs. married [A, B]; single vs. married [C, D]; separated/divorced vs. married [E, F]; widowed vs. married [G, H]) and survival in male and female patients, respectively. 95% CIs were indicated by vertical bars. CSS, cause‐specific survival; OS, overall survival; HR, hazard ratio; CI, confidence interval.